Press release
Renal Disease Market is expected to generate US$ 14291.2 million at a CAGR growth of ~6.3% by the review period of 2023 | Top Key Players Abbott (US), Amgen Inc. (US), Baxter (US), Bristol-Myers Squibb Company (US), Keryx Biopharmaceuticals, Inc. (US), Ne
Diseases of the nephrons of the kidney are termed as renal diseases or nephropathy or kidney diseases. The market for global renal disease is expected to generate US$ 14291.2 million at a CAGR growth of ~6.3% by the review period of 2023.Large and growing unmet need, low flexibility of demand for treatment due to the serious nature of the ailment, and growing screening are the critical drivers of the market. National Health Interview Survey, 2015, estimates that 4.9 million, representing 2.0 % of adults were diagnosed with kidney disease in 2015 alone. The low flexibility of demand for treatment is reflected by the large mortality rate of 15.1 deaths per 100,000 population, which makes renal disease the 9th largest cause of deaths in the U.S. thus a large market is easily comprehendible.
Get a sample report at https://www.marketresearchfuture.com/sample_request/3167 .
Prominent Players for Global Renal disease Market:
Sanofi, Abbott, Shire Pharmaceuticals Limited, NephroGenex, Inc., Amgen Inc., Baxter, Bristol-Myers Squibb Company, Pfizer Inc., Novartis AG, Keryx Biopharmaceuticals, Inc., and others.
The growth is risk factors associated with kidney diseases such as alcoholism, high blood pressure, diabetes and others is the second important driver. According to the National Institute of Diabetes and Digestive and Kidney Diseases approximately half cases of kidney diseases are associated with diabetes, cardiovascular diseases and other ailments.
The high demand for sustenance treatment such as dialysis is further stimulation the market as can be seen from the data of National Institute of Diabetes and Digestive and Kidney Diseases which predict 468,000 U.S. patients are on dialysis with 661,000 Americans suffering from kidney failure. The figures for kidney transplant corresponds roughly to 193,000 patients in U.S. alone in 2015. Other drivers of the market are growing geriatric population, rising incomes and others.
Restraints
High cost of treatment especially the dialysis equipment and kidney transplant surgeries are the critical restraints on the market.
Segments of Global Renal disease Market:
Type - acute kidney problems (pre-renal, post-renal, renal), chronic kidney diseases, and others.
Diagnosis - Blood Tests (serum creatinine, glomerular filtration rate (GFR), blood urea nitrogen (BUN), fasting blood glucose test), urine test (urinalysis, protein urine test, micro albuminuria test, creatinine clearance test), imaging test (ultrasound, CT scan), biopsy and others.
Treatment - Drugs (anti-hypertensive drugs, anti-hyperlipidemia drugs, anti-anemic drugs, anti-inflammatory drugs, diuretic and others), Dialysis (hemodialysis, peritoneal dialysis), kidney transplant (deceased-donor kidney transplant, living-donor kidney transplant, pre-emptive kidney transplant), surgery (nephrectomy and radical nephrectomy, nephron-sparing surgery (NSS), nephrolithotripsy, extracorporeal shock wave lithotripsy (ESWL), and others), diet control and others.
More inquire at https://www.marketresearchfuture.com/enquiry/3167 .
Regional Analysis of Global Renal disease Market:
North America is expected to be the largest market for global renal disease banking on high incidence rate and the huge reimbursement. The kidney disease costs Medicare program more than USD 50 billion in 2015, representing more than 20 percent of all Medicare spending. The fee for service provisions of end stage renal diseases rose from USD 30.4 billion in 2012 to USD 30.9 billion in 2013, which represents a 1.6 % increase.
The European region is anticipated to be the second largest market led by Germany, France and the U.K. Asia-Pacific (APAC) is expected to generate the fastest growth led by China, and India. Asians have 1.4 times higher risk of developing renal diseases than Caucasians. Also Diabetes is the leading cause of renal diseases. According to American Kidney Fund, Inc. report, Diabetes is the leading cause of renal diseases causes responsible for a whopping 44% of all cases of kidney failure. India has approximately 50 million diabetes patients, which is anticipated to reach 87 million patients in 2030. Thus the diabetes capital of the world is the future market for the kidney diseases.
Middle east and Africa (ME&A) market is constrained by poor per capita income, low awareness and political conditions. However the African continent also displays the largest unmet need as Africans are almost 4 times at a higher risk to develop renal diseases as compared to Caucasians.
About us
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
P: +1 646 845 9312
W: www.marketresearchfuture.com
sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Renal Disease Market is expected to generate US$ 14291.2 million at a CAGR growth of ~6.3% by the review period of 2023 | Top Key Players Abbott (US), Amgen Inc. (US), Baxter (US), Bristol-Myers Squibb Company (US), Keryx Biopharmaceuticals, Inc. (US), Ne here
News-ID: 991760 • Views: …
More Releases from Market Research Future

Global Small Boat Industry Sees Growing Demand Amid Rising Recreational Boating …
As per the latest analysis by Market Research Future, the Small Boats Market Size was estimated at 17.12 (USD Billion) in 2024. The Small Boats Market Industry is expected to grow from 17.88 (USD Billion) in 2025 to 26.41 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.43% during the forecast period (2025 - 2034).
The global small boat industry is witnessing significant growth, driven…

Automotive Trim Market Attaining USD 193.22 Billion till 2034 | Innovations Rede …
As per the latest analysis by Market Research Future, the Automotive Trim Market Size was estimated at 140.30 (USD Billion) in 2024. The Automotive Trim Market Industry is expected to grow from 144.87 (USD Billion) in 2025 to 193.22 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 3.25% during the forecast period (2025 - 2034).
The automotive industry is witnessing a significant transformation in vehicle…

Leading Automotive Technology Firms Expand Fuel Level Sensor Solutions for Next- …
As per the latest analysis by Market Research Future, Automotive Fuel Level Sensor Market Size was valued at USD 5,788.04 million in 2024. The Automotive Fuel Level Sensor market industry is projected to grow from USD 6,008.32 million in 2025 to USD 9,201.90 million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.35% during the forecast period (2024 - 2035).
With the global automotive industry focused on precision,…

Valet Parking Technology Gains Momentum as Urban Mobility and Smart Infrastructu …
As per the latest analysis by Market Research Future, the Valet Parking Technology Market Size was estimated at 1.41 (USD Billion) in 2024. The Valet Parking Technology Market Industry is expected to grow from 1.63 (USD Billion) in 2025 to 6.01 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 15.62% during the forecast period (2025 - 2034).
Valet parking technology is emerging as a transformative…
More Releases for Renal
Advancements in Renal Dialysis Equipment Trend: A Crucial Influence on the Renal …
What market dynamics are playing a key role in accelerating the growth of the renal dialysis equipment market?
The escalating incidence of chronic kidney disease is projected to boost the expansion of the renal dialysis equipment market. Chronic kidney disease, a term that describes the slow and progressive decline of kidney function, can ultimately result in kidney failure and other severe health conditions. This disease is linked with several risk factors…
Renal Osteodystrophy Market: An In-Depth Analysis
The Renal Osteodystrophy Market was valued at approximately USD 2.4 billion in 2023 and is projected to reach around USD 7.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2024 to 2032.
Renal Osteodystrophy Market Overview
The Renal Osteodystrophy Market is experiencing significant growth, driven by the increasing prevalence of chronic kidney disease (CKD) and the associated bone disorders. Advancements in diagnostic techniques have enhanced early…
Shaping the Renal Dialysis Equipment Market in 2025: Advancements in Renal Dialy …
How Big Is the Renal Dialysis Equipment Market Expected to Be, and What Will Its Growth Rate Be?
In recent years, the renal dialysis equipment market has seen robust growth. It's projected to increase from $19.52 billion in 2024 to $20.92 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.2%. Factors contributing to growth in the historic period include comprehensive training and support programs, substantial research and development…
Transforming the Veterinary Renal Disease Market in 2025: Increasing Pet Ownersh …
"What Is the Expected Size and Growth Rate of the Veterinary Renal Disease Market?
The market size for veterinary kidney diseases has seen profound growth recently. It is set to expand from $15.5 billion in 2024 to $16.63 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Several factors contributed to this growth during the historical period, including heightened initiatives to increase disease awareness, a shift in…
Renal Cancer Pipeline Outlook Report 2024
DelveInsight's, "Renal Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Renal Cancer companies and 80+ pipeline drugs in the Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Renal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways…
Renal Biomarker Market to register a CAGR of 7.0% by 2026: Rising Prevalence of …
Future Market Insights delivers key insights on the global renal biomarker market in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast period…